Literature DB >> 30420624

Metabolic reprogramming of natural killer cells in obesity limits antitumor responses.

Xavier Michelet1,2, Lydia Dyck3, Andrew Hogan4, Roisin M Loftus3, Danielle Duquette1, Kevin Wei1, Semir Beyaz2, Ali Tavakkoli1, Cathriona Foley3, Raymond Donnelly3, Cliona O'Farrelly3, Mathilde Raverdeau3, Ashley Vernon1, William Pettee1, Donal O'Shea4,5, Barbara S Nikolajczyk6, Kingston H G Mills3, Michael B Brenner1,2, David Finlay3,7, Lydia Lynch8,9,10.   

Abstract

Up to 49% of certain types of cancer are attributed to obesity, and potential mechanisms include overproduction of hormones, adipokines, and insulin. Cytotoxic immune cells, including natural killer (NK) cells and CD8+ T cells, are important in tumor surveillance, but little is known about the impact of obesity on immunosurveillance. Here, we show that obesity induces robust peroxisome proliferator-activated receptor (PPAR)-driven lipid accumulation in NK cells, causing complete 'paralysis' of their cellular metabolism and trafficking. Fatty acid administration, and PPARα and PPARδ (PPARα/δ) agonists, mimicked obesity and inhibited mechanistic target of rapamycin (mTOR)-mediated glycolysis. This prevented trafficking of the cytotoxic machinery to the NK cell-tumor synapse. Inhibiting PPARα/δ or blocking the transport of lipids into mitochondria reversed NK cell metabolic paralysis and restored cytotoxicity. In vivo, NK cells had blunted antitumor responses and failed to reduce tumor growth in obesity. Our results demonstrate that the lipotoxic obese environment impairs immunosurveillance and suggest that metabolic reprogramming of NK cells may improve cancer outcomes in obesity.

Entities:  

Mesh:

Year:  2018        PMID: 30420624     DOI: 10.1038/s41590-018-0251-7

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  157 in total

1.  Immunometabolism: From basic mechanisms to translation.

Authors:  Liza Makowski; Mehdi Chaib; Jeffrey C Rathmell
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

2.  Supplemental estrogen and caloric restriction reduce obesity-induced periprostatic white adipose inflammation in mice.

Authors:  Priya Bhardwaj; Takahiro Ikeda; Xi Kathy Zhou; Hanhan Wang; Xi Emily Zheng; Dilip D Giri; Olivier Elemento; Akanksha Verma; Miki Miyazawa; Sushmita Mukherjee; Domenick J Falcone; Nils K Wendel; Douglas S Scherr; Andrew J Dannenberg
Journal:  Carcinogenesis       Date:  2019-07-20       Impact factor: 4.944

3.  GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials.

Authors:  Chuqing Cao; Shuting Yang; Zhiguang Zhou
Journal:  Endocrine       Date:  2019-08-16       Impact factor: 3.633

4.  Targeting the adipose tissue to fight prostate cancer.

Authors:  Silvano Paternoster; Marco Falasca
Journal:  Transl Androl Urol       Date:  2019-07

5.  Maternal obesity is associated with phenotypic alterations in fetal immune cells by single-cell mass cytometry.

Authors:  Elizabeth Ann L Enninga; Jin Sung Jang; Benjamin Hur; Erica L Johnson; Myra J Wick; Jaeyun Sung; Rana Chakraborty
Journal:  Am J Reprod Immunol       Date:  2020-11-04       Impact factor: 3.886

Review 6.  Metastasis as a systemic disease: molecular insights and clinical implications.

Authors:  Maša Alečković; Sandra S McAllister; Kornelia Polyak
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-06-14       Impact factor: 10.680

7.  Polarized mitochondria as guardians of NK cell fitness.

Authors:  Laura Surace; Jean-Marc Doisne; Pedro Escoll; Solenne Marie; Valerie Dardalhon; Carys Croft; Anna Thaller; Davide Topazio; Angelo Sparaneo; Antonia Cama; Olimpia Musumeci; Aurelio d'Ecclesia; Carmen Buchrieser; Naomi Taylor; James P Di Santo
Journal:  Blood Adv       Date:  2021-01-12

Review 8.  Lipid Metabolism in Tumor-Associated Natural Killer Cells.

Authors:  Yu Chen; Meihua Sui
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma.

Authors:  L Tao; S Wang; L Yang; L Jiang; J Li; X Wang
Journal:  Clin Exp Immunol       Date:  2020-05-17       Impact factor: 4.330

Review 10.  Obesity and CD8 T cell metabolism: Implications for anti-tumor immunity and cancer immunotherapy outcomes.

Authors:  William J Turbitt; Claire Buchta Rosean; K Scott Weber; Lyse A Norian
Journal:  Immunol Rev       Date:  2020-03-10       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.